Search

everythinglearnresearchcommunity

for

Search:↓

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Improved understanding of stem cell mechanisms can enhance skin tissue engineering.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Stem cells can create hair follicles, potentially treating permanent hair loss, and healthy skin and hair depend on mitochondrial function and special fats.

Some breast cancer chemotherapy can cause permanent hair loss.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Hair follicle bumps with stem cells might contribute to permanent hair loss by getting disconnected due to scarring.

A specific mutation in the TRPV3 gene causes hair follicle cells to develop improperly, leading to hair loss.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Melatonin may help prevent hair loss caused by the chemotherapy drug paclitaxel.

Higher doses of cranial irradiation are linked to permanent hair loss.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Some cancer treatments can cause permanent hair loss.

Arrector pili muscle regulates hair follicle stem cells, DNA methylation needed for hair cycling, and Wnt/B-catenin signaling starts hair growth.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.